Generic Levitra: Affordable ED Drugs

Levitra sales topped $250 million in 2015. And while that’s not much compared to the $2B of sales from Viagra in 2017, Levitra is still a major player in the ED market. But Bayer’s patent for Levitra (vardenafil) expires on October 31, 2018, opening the way for generic Levitra. Expiring prescription drug patents typically drive prices down, thanks to generic alternatives to expensive brand-name drugs. Levitra is no exception. A generic alternative to Levitra is a big deal to men struggling with erectile dysfunction (ED). And it’s not the only ED prescription medication patent set to expire soon. Both Cialis (Tadalafil) and Viagra (Sildenafil) should have generic versions available soon. Here’s the potential timeline of generic ED medication in the US.

Generic ED Medication: Viagra, Cialis, and Levitra

generic ED medication

Generic Viagra: Already Here

Sildenafil Viagra’s patent protection ends in 2020. However, Pfizer reached an agreement with Teva Pharmaceuticals to create a generic Viagra that’s already available. Teva is the only pharmaceutical company making generic Viagra—called Sildenafil—so the pressure from competition isn’t going to drive prices down like other generic medications. At least not right away.

Generic Cialis: Not Yet

Cialis Eli Lilly, the makers of Cialis, announced in July 2017, that Cialis would not come off patent protection in November 2017, as expected. They arrived at a new, patent settlement with multiple, generic pharmaceutical companies to extend Lilly’s protection of Cialis until September 27, 2018. The fact that the agreement includes multiple pharmaceutical companies and the rapidly approaching expiration date means that the price of generic Cialis should come down soon—thanks to the competition.

Generic Levitra: Coming Soon?

Levitra French pharmaceutical company, Sanofi, has acquired the rights to make generic Levitra in the United States, Australia, Canada, and Europe. When Levitra’s patent expires October 31, 2018, they can start producing generic Levitra to compete with generic Cialis and generic Viagra. Generic Levitra isn’t necessarily coming later this year, but the price of Levitra will likely drop as many other generic ED drugs become be available around the same time, even if a generic alternative isn’t on the market right away.

Levitra Over-the-Counter ED Medication

Levitra’s patent is set to expire in October 2018. But as of June 2018, Bayer doesn’t have any plans to make or market Levitra as an over-the-counter (OTC) erectile dysfunction drug. However, French pharmaceutical company, Sanofi, has acquired the right to make all applications for OTC approval of Levitra in the United States, Australia, Canada, and Europe when Levitra’s patent expires. But there are a number of regulations and concerns for over-counter ED medication.

Over-the-Counter ED Medication: Levitra

Levitra Just because the patent on Levitra expires in October 2018, doesn’t mean that over-the-counter Levitra is a guarantee. OTC Levitra faces enormous obstacles in the United States and Europe. Pfizer faced similar difficulties back in 2008 when they tried to gain approval for OTC Viagra sales. Levitra is a prescription medication for a number of reasons including potentially dangerous drug interactions with other medications and even daily vitamins and natural supplements. It’s also important to take the proper dose of ED medication to avoid harmful side effects. More isn’t always better, and concerns about the potential for misuse, the complicated educational material needed to accompany the medication, and the fact that the underlying medical conditions leading to ED would go untreated, are all problems for over-the-counter Levitra.

Erectile Dysfunction Prescription Medication & Treatment

Erectile dysfunction doesn’t happen for no reason. In fact, ED is usually a sign of a much more serious underlying health condition like: It’s important to understand what’s actually causing your erectile dysfunction before medicating the condition. Getting a prescription for ED meds is an opportunity for doctors to diagnose and educate men about the root causes and habits that can not only lead to ED but other life-threatening conditions. While telemedicine and online diagnosis have lowered the barrier to entry for a lot of men suffering with ED, it’s hard to imagine any of the erectile dysfunction drugs becoming available over-the-counter any time soon. Especially in the United States.